• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

982
82
61
58
47

COUNTRY

56
19
10
6
5

CATEGORIES

  • 82
  • 120
  • 66
  • 66
  • 36
  • 37
  • 11
  • 11
  • 12
  • 18

PRICE

550
813
1,789
2,612

PUBLISHED

63
244
684
2,612

PRODUCT TYPE

2,461
76
62
12
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the B-Cell...

March 2014
FROM

Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014

Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014" provides data on the Low-Grade Astrocytoma...

March 2014
FROM

Low-Grade Glioma Global Clinical Trials Review, H1, 2014

Low-Grade Glioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H1, 2014" provides data on the Low-Grade Glioma clinical...

March 2014
FROM

Malignant Ascites Global Clinical Trials Review, H1, 2014

Malignant Ascites Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Malignant Ascites Global Clinical Trials Review, H1, 2014" provides data on the Malignant Ascites clinical...

March 2014
FROM

Malignant Glioma Global Clinical Trials Review, H1, 2014

Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Glioma clinical...

March 2014
FROM

THERAPEUTIC REVOLUTION The History of Medical Oncology from Early Days to the Creation of the Subspecialty

Cancer is a disease responsible for several million annual deaths among humans, worldwide However, advances in healthcare - which include breakthroughs in science and medicine as well as access to medical...

March 2014

Chemotherapy Induced Anemia - Pipeline Review, H1 2014

Chemotherapy Induced Anemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2014’, provides an overview of the Chemotherapy Induced Anemia’s...

March 2014
FROM

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some...

March 2014
FROM

Neuroblastoma Global Clinical Trials Review, H1, 2014

Neuroblastoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Neuroblastoma Global Clinical Trials Review, H1, 2014" provides data on the Neuroblastoma clinical trial scenario....

March 2014
FROM

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review,...

March 2014
FROM

Meningioma Global Clinical Trials Review, H1, 2014

Meningioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Meningioma Global Clinical Trials Review, H1, 2014" provides data on the Meningioma clinical trial scenario....

March 2014
FROM

Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014

Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014"...

March 2014
FROM

Penile Cancer Global Clinical Trials Review, H1, 2014

Penile Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Penile Cancer Global Clinical Trials Review, H1, 2014" provides data on the Penile Cancer clinical trial scenario....

March 2014
FROM

Cholangiocellular Hepatoma Global Clinical Trials Review, H1, 2014

Cholangiocellular Hepatoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Cholangiocellular Hepatoma Global Clinical Trials Review, H1, 2014" provides data on the Cholangiocellular...

March 2014
FROM

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014" provides data...

March 2014
FROM

Malignant Mesothelioma Global Clinical Trials Review, H1, 2014

Malignant Mesothelioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Mesothelioma...

March 2014
FROM

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal...

March 2014
FROM

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014" provides data on the Chemotherapy...

March 2014
FROM
Analytical Tool - Hematological Cancers Analytical Tool - Hematological Cancers - Product Thumbnail Image

Analytical Tool - Hematological Cancers

"Analytical Tool – Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It...

March 2014
Analytical Tool - Antibodies and Peptides in Oncology Analytical Tool - Antibodies and Peptides in Oncology - Product Thumbnail Image

Analytical Tool - Antibodies and Peptides in Oncology

"Analytical Tool – Antibodies and Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody...

March 2014
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)